SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on SMS Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
SMS Pharmaceuticals Ltd Share Price Chart
SMS Pharmaceuticals Ltd Fundamentals
Traded Volume: 1,34,214
Market Cap(Cr): 2,640
Avg Traded Price 282.62
1 Year return 17.80%
Upper Circuit 286
Lower Circuit 278.5
P/E TTM 30.00
P/B Ratio 10.00
Traded Value(Cr) 378.35
EPS TTM 9.516
Book value 9.516
Dividend 0.00%
SMS Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights SMS Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the SMS Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -2.93%
1M -3.06%
3M +18.09%
1Y +17.80%
YTD +10.60%
SMS Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights SMS Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 98801.00
Day Before Yesterday 98553.00
1W Avg 1.71L
1M Avg 6.47L
3M Avg 7.56L
SMS Pharmaceuticals Ltd Technical Details
SMS Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 278
Support 2 275
Support 3 271
Pivot Point : 282
Resistance 1 286
Resistance 2 290
Resistance 3 293
SMS Pharmaceuticals Ltd Corporate Actions
SMS Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on SMS Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 22-Sep-2025 Type D Description 0.40/share@40.00% Record Date 22-Sep-2025 Ratio 40.00
Ex-Date 23-Sep-2024 Type D Description 0.40/share@40.00% Record Date 23-Sep-2024 Ratio 40.00
Ex-Date 22-Sep-2023 Type D Description 0.30/share@30.00% Record Date 22-Sep-2023 Ratio 30.00
Ex-Date 22-Sep-2022 Type D Description 0.30/share@30.00% Record Date 23-Sep-2022 Ratio 30.00
Ex-Date 22-Sep-2021 Type D Description 0.30/share@30.00% Record Date - Ratio 30.00
Ex-Date 26-Mar-2020 Type D Description 0.25/share@25.00% Record Date 28-Mar-2020 Ratio 25.00
Ex-Date 19-Sep-2019 Type D Description 0.25/share@25.00% Record Date - Ratio 25.00
Ex-Date 11-Sep-2018 Type D Description 0.25/share@25.00% Record Date - Ratio 25.00
Ex-Date 20-Sep-2017 Type D Description 0.20/share@20.00% Record Date - Ratio 20.00
Ex-Date 22-Sep-2016 Type D Description 0.20/share@20.00% Record Date - Ratio 20.00
Ex-Date 17-Dec-2015 Type S Description share@1:10.00 Record Date 18-Dec-2015 Ratio 1:10.00
Ex-Date 22-Sep-2015 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 23-Sep-2014 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 23-Sep-2013 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 22-Sep-2011 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 23-Sep-2010 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Ex-Date 23-Sep-2009 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 23-Dec-2008 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 21-Sep-2007 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Dividends
Announcement Date 22-Sep-2025 Ex Dividend Date 22-Sep-2025 Dividend(%) 40
Announcement Date 23-Sep-2024 Ex Dividend Date 23-Sep-2024 Dividend(%) 40
Announcement Date 22-Sep-2023 Ex Dividend Date 22-Sep-2023 Dividend(%) 30
Announcement Date 22-Sep-2022 Ex Dividend Date 22-Sep-2022 Dividend(%) 30
Announcement Date 22-Sep-2021 Ex Dividend Date 22-Sep-2021 Dividend(%) 30
Announcement Date 26-Mar-2020 Ex Dividend Date 26-Mar-2020 Dividend(%) 25
Announcement Date 19-Sep-2019 Ex Dividend Date 19-Sep-2019 Dividend(%) 25
Announcement Date 11-Sep-2018 Ex Dividend Date 11-Sep-2018 Dividend(%) 25
Announcement Date 20-Sep-2017 Ex Dividend Date 20-Sep-2017 Dividend(%) 20
Announcement Date 22-Sep-2016 Ex Dividend Date 22-Sep-2016 Dividend(%) 20
Announcement Date 22-Sep-2015 Ex Dividend Date 22-Sep-2015 Dividend(%) 20
Announcement Date 23-Sep-2014 Ex Dividend Date 23-Sep-2014 Dividend(%) 20
Announcement Date 23-Sep-2013 Ex Dividend Date 23-Sep-2013 Dividend(%) 20
Announcement Date 22-Sep-2011 Ex Dividend Date 22-Sep-2011 Dividend(%) 15
Announcement Date 23-Sep-2010 Ex Dividend Date 23-Sep-2010 Dividend(%) 10
Announcement Date 23-Sep-2009 Ex Dividend Date 23-Sep-2009 Dividend(%) 20
Announcement Date 23-Dec-2008 Ex Dividend Date 23-Dec-2008 Dividend(%) 20
Announcement Date 21-Sep-2007 Ex Dividend Date 21-Sep-2007 Dividend(%) 20
Bonus
No Bonus has been declared by SMSPHARMA
Splits
Record Date 18-Dec-2015 Split Date 17-Dec-2015 Face Value (Before/After) 10.00/1.00
Others
Rights No Rights has been declared by SMSPHARMA
SMS Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares SMS Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate SMS Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Stock Name Hikal Ltd ₹224.98 (-1.46%) M. Cap (Cr) 27.74 1 Yr Return (%) -41.82% P/E (TTM) 274.66 PB Ratio 2.20
Stock Name IOL Chemicals & Pharmaceuticals Ltd ₹90.32 (-1.42%) M. Cap (Cr) 26.51 1 Yr Return (%) +32.14% P/E (TTM) 22.88 PB Ratio 1.60
Stock Name Alembic Ltd ₹98.51 (-0.44%) M. Cap (Cr) 25.30 1 Yr Return (%) -20.08% P/E (TTM) 7.81 PB Ratio 1.08
Stock Name SMS Pharmaceuticals Ltd ₹281.90 (-0.70%) M. Cap (Cr) 26.40 1 Yr Return (%) +17.80% P/E (TTM) 29.62 PB Ratio 4.43
Stock Name Solara Active Pharma Sciences Ltd ₹547.70 (-2.73%) M. Cap (Cr) 19.81 1 Yr Return (%) -28.07% P/E (TTM) 380.12 PB Ratio 2.23
Stock Name Morepen Laboratories Ltd ₹44.01 (-1.83%) M. Cap (Cr) 24.12 1 Yr Return (%) -39.90% P/E (TTM) 24.45 PB Ratio 2.09
Stock Name Indoco Remedies Ltd ₹257.25 (+2.06%) M. Cap (Cr) 23.73 1 Yr Return (%) -14.19% P/E (TTM) -21.48 PB Ratio 2.18
SMS Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by SMS Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 81.71 Mar 2024 50.12 Mar 2023 22.45 Mar 2022 40.23 Mar 2021 90.45
PARTICULARS Investing Activities Mar 2025 -123.44 Mar 2024 -52.07 Mar 2023 -29.69 Mar 2022 -27.15 Mar 2021 -151.59
PARTICULARS Financing Activities Mar 2025 47.08 Mar 2024 30.68 Mar 2023 -31.97 Mar 2022 -6.92 Mar 2021 92.02
PARTICULARS Net Cash Flow Mar 2025 5.35 Mar 2024 28.73 Mar 2023 -39.20 Mar 2022 6.16 Mar 2021 30.88
SMS Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of SMS Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 68.07%
Public 28.77%
Other Institutions 0.0%
FII 0.28%
Mutual Funds 2.88%
About SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Limited was incorporated in December, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh.During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24.During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s. VKT Pharma Private Limited. With this the said company has become an associate company. The project of the said associate company is in final stage and at the verge of completion and operations are yet to be commenced. The Company has not having any subsidiaries.During the year 2015-16, the Company had sub divided the face value of share of Rs 10/- each into face value of Rs 1/- of each with record date of 18th December 2015.During FY 2015-16, the Board has approved the Draft Scheme of Arrangement for Demerger of Semi Regulated Units (Unit - I, IV & V) along with other Assets to transfer the same to SMS Lifesciences India Limited (Resulting Company), with an object to reduce the impact of Semi Regulated Units on Regulated Units, achieving operational efficiencies, site synergies and streamlining its current structure. The Draft Scheme of Arrangement is subject to the Approvals of Stock Exchanges, Securities Board of India Limited, Reserve Bank of India and other regulatory authorities and also Hon'ble High Court of Judicature at Hyderabad for the State of Telangana and Andhra Pradesh.During FY 2016-17, the Company had made investment in it's associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 2016-17, the Company had acquired 5,11,400 equity shares of face value of Rs 10/- each in the said associate at an average price of Rs 157.21. Further, the Company had also made an investment in 1000 equity shares of Sireen Drugs Private Limited of Rs 10/- each.SMS Lifesciences India Limited is the wholly owned subsidiary of the Company during the Financial Year 2016-17.The Semi Regulatory Units of the Company were demerged and transferred to SMS Lifesciences India Limited effective from 01-04-2016 and SMS LifeSciences India Limited was made a Wholly Owned Subsidiary of the Company in 2017. The said Scheme became effective from 17th May, 2017. In terms of the said Scheme, the Company allotted 30,23,287 equity shares of Rs.10/- each to the shareholders of the company on 23rd June, 2017. The Company had made investment in its associate company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 2017-18, the Company had acquired 7,84,100 equity shares of face value of Rs.10/- each in the said associate at an average price of Rs.200.81.During FY 2018-19, the Company had made investment in it's associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. The Company held 38,50,165 equity shares of Rs 10/- each in VKT Pharma Private Limited as on 31st March 2019 as investments.In 2020-21, the Company incorporated Joint Venture (JV) in Spain with nomenclature of CHEMO SMS ENTERPRISES SL in the capital ratio of 55:45. The Ibuprofen product got launched in 2023. Ibuprofen production capacity has been expanded by 1,300 KL at Visakhapatnam facility in FY 2025. The Company has maintained strong growth in high-value APIs across therapeutic segments such as anti-diabetic, anti-epileptic and anti-erectile dysfunction in 2025.
Chairman & Managing Director
P Ramesh Babu
Registered office 19 III Rd 71 Opp Bharatividya, Bhavan Public Sch Jubilee Hill, Hyderabad, Telangana, 500096
FAX :91-40-66288888
Background
Incorporation Year 1987
Face Value ₹1.00
Market Lot 1
FAQs on SMS Pharmaceuticals Ltd
How to buy SMS Pharmaceuticals Ltd shares on NSE?
To buy SMS Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the SMS Pharmaceuticals Ltd share price today?
The SMS Pharmaceuticals Ltd share price on NSE is ₹281.90 today.
What is the market cap of SMS Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹2640.05.
What is the PE & PB ratio of SMS Pharmaceuticals Ltd?
PE is 30 and PB is 10.
What is the 52 Week High and Low of SMS Pharmaceuticals Ltd shares?
SMS Pharmaceuticals Ltd stock price high: ₹328.90 SMS Pharmaceuticals Ltd stock price low: ₹176.05.